These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6875857)

  • 21. Reversible alterations in hypothalamic uptake of biogenic amines after septal lesions.
    Thompson RG; Valdes JJ; Gage FH
    Exp Neurol; 1981 Nov; 74(2):356-69. PubMed ID: 7297624
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus.
    Brunetti L; Orlando G; Recinella L; Michelotto B; Ferrante C; Vacca M
    Eur J Pharmacol; 2004 Jun; 493(1-3):41-4. PubMed ID: 15189762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of reserpine and tetrabenazine on the accumulation of noradrenaline in the rat sciatic nerve after ligation.
    Dahlström A
    Acta Physiol Scand; 1967 Mar; 69(3):167-79. PubMed ID: 6034286
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotoninergic control of growth hormone secretion: hypothalamic dopamine, norepinephrine, and serotonin levels and metabolism in three hyposomatotropic rat models and in normal rats.
    Smythe GA; Duncan MW; Bradshaw JE; Cai WY
    Endocrinology; 1982 Feb; 110(2):376-83. PubMed ID: 7056204
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exogenous dopamine on hypothalamic dopamine and norepinephrine concentrations in the neonatal brain in rats.
    Ohkura T; Lee JW; Hagino N
    Int J Dev Neurosci; 1986; 4(2):129-33. PubMed ID: 3455577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of calcium on catecholamine synthesis regulation in olfactory tubercle and hypothalamic synaptosomes.
    Haycock DA; Greenblatt SE; Askins HL; Patrick RL
    Brain Res; 1984 May; 299(1):15-23. PubMed ID: 6426701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine.
    Carlsson A; Lindqvist M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):112-20. PubMed ID: 6013085
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of dopa on the norepinephrine and dopamine contents and on the granulated vesicles of the hypothalamus of reserpinized rabbits.
    Hashimoto Y; Ishii S; Ohi Y; Shimizu N; Imaizumi R
    Jpn J Pharmacol; 1965 Dec; 15(4):395-400. PubMed ID: 5296051
    [No Abstract]   [Full Text] [Related]  

  • 30. The depletion and recovery of noradrenaline in the brain and some sympathetically innervated mammalian tissues after tetrabenazine.
    Häggendal J
    J Pharm Pharmacol; 1968 May; 20(5):364-7. PubMed ID: 4385439
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification by desipramine (DMI) of the availability of norepinephrine released by reserpine in the hypothalamus of the rat in vivo.
    Sulser F; Owens ML; Strada SJ; Dingell JV
    J Pharmacol Exp Ther; 1969 Aug; 168(2):272-82. PubMed ID: 5803311
    [No Abstract]   [Full Text] [Related]  

  • 32. [Catecholamine levels in the striatum, hypothalamus, and adrenals of rats with genetic predisposition to epileptic seizures].
    Dolina SA; Kogan BM; Tananova GV
    Biull Eksp Biol Med; 1982 Feb; 93(2):12-4. PubMed ID: 7066515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro studies on central and peripheral monoamine neurons at the ultrastructural level.
    Hökfelt T
    Z Zellforsch Mikrosk Anat; 1968; 91(1):1-74. PubMed ID: 5724812
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of bradykinin in vitro on uptake and release of dopamine by rat striatal synaptosomes.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1981; 33(6):585-92. PubMed ID: 7347810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 36. On the brain monoaminergic systems relating to ejaculation. I. Brain dopamine and ejaculation.
    Kimura Y; Kisaki N; Sakurada S; Tadano T
    Andrologia; 1976; 8(4):313-20. PubMed ID: 1008262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mode of action of tetrabenazine on peripheral noradrenergic nerves.
    Tomlinson DR
    Br J Pharmacol; 1977 Nov; 61(3):339-44. PubMed ID: 588801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice.
    Dluzen DE; Story GM; Xu K; Kucera J; Walro JM
    Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibitory effect of noradrenaline on dopamine release from the hypothalamus of the rat].
    Le Quan-Bui KH; Elghozi JL; Earnhardt JT; Meyer P; Devynck MA
    J Pharmacol; 1982; 13(3):381-8. PubMed ID: 7132373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma corticosterone following alterations of hypothalamic catecholamines in rats.
    Sigg EB; Keim KL
    Pharmacol Biochem Behav; 1976 Jan; 4(1):95-7. PubMed ID: 1265099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.